PETALING JAYA, Malaysia, Jul 13, 2022 – (ACN Newswire via SEAPRWire.com) – Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. Azri Azerai, […]

HONG KONG, Mar 31, 2022 – (ACN Newswire via SEAPRWire.com) – Weichai Power Company Limited (“Weichai Power” or the “Company”, SEHK stock code: 2338.HK; Shenzhen Stock Exchange stock code: 000338.SZ) announced its annual results for the year ended 31 December 2021 (the “year”) on 30th March, prepared in accordance with […]

TOKYO, Mar 7, 2022 – (JCN Newswire via SEAPRWire.com) – Fujitsu and the Tokyo Medical and Dental University (TMDU) today announced a new technology that uses AI to discover new causal mechanisms of drug resistance in cancer treatments from clinical data. Leveraging the world’s fastest supercomputer “Fugaku,”(1) the new technology […]

HONG KONG, Jan 13, 2022 – (ACN Newswire via SEAPRWire.com) – At 9:00 am on January 8, 2022, Weichai Power (Stock codes: 2338.HK; 000338.SZ) released the world’s first diesel engine with a base engine thermal efficiency of 51.09% and major achievements in hydrogen technology achievements. Tan Xuguang, CPC Secretary and […]

TOKYO and KENILWORTH, N.J., Nov 29, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced that the European Commission has approved the combination of LENVIMA (KISPLYX in the European Union [EU] for […]

TOKYO and KENILWORTH, N.J., Oct 18, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. (known as MSD outside the United States and Canada) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted […]